|
Prognosis/ Outcomes
Citations 11-20 of 133 total displayed.
|
Past content
(since May 1998):
|
- Original Contributions
Association Between Clinical Conversion to Multiple Sclerosis in Radiologically Isolated Syndrome and Magnetic Resonance Imaging, Cerebrospinal Fluid, and Visual Evoked Potential: Follow-up of 70 Patients
- Christine Lebrun; Caroline Bensa; Marc Debouverie; Sandrine Wiertlevski; David Brassat; Jerome de Seze; Lucien Rumbach; Jean Pelletier; Pierre Labauge; Bruno Brochet; Ayman Tourbah; Pierre Clavelou; for the Club Francophone de la Sclérose en Plaques
Arch Neurol 2009; 66: 841-846.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Defining Survival as an Outcome Measure in Amyotrophic Lateral Sclerosis
- Paul H. Gordon; Philippe Corcia; Lucette Lacomblez; Ksenia Pochigaeva; Jean-Louis Abitbol; Merit Cudkowicz; P. Nigel Leigh; Vincent Meininger
Arch Neurol 2009; 66: 758-761.
[Abstract]
[Full text]
[PDF]
[ eTable ]
- Clinical Trials
Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
- Parkinson Study Group CALM Cohort Investigators
Arch Neurol 2009; 66: 563-570.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Reduction of SorLA/LR11, a Sorting Protein Limiting β-Amyloid Production, in Alzheimer Disease Cerebrospinal Fluid
- Qiu-Lan Ma; Douglas R. Galasko; John M. Ringman; Harry V. Vinters; Steven D. Edland; Justine Pomakian; Oliver J. Ubeda; Emily R. Rosario; Bruce Teter; Sally A. Frautschy; Greg M. Cole
Arch Neurol 2009; 66: 448-457.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Effect of Anti-CD25 Antibody Daclizumab in the Inhibition of Inflammation and Stabilization of Disease Progression in Multiple Sclerosis
- Bibiana Bielekova; Thomas Howard; Amy N. Packer; Nancy Richert; Gregg Blevins; Joan Ohayon; Thomas A. Waldmann; Henry F. McFarland; Roland Martin
Arch Neurol 2009; 66: 483-489.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Differentiation of Hereditary Spastic Paraparesis From Primary Lateral Sclerosis in Sporadic Adult-Onset Upper Motor Neuron Syndromes
- Frans Brugman; Jan H. Veldink; Hessel Franssen; Marianne de Visser; J. M. B.Vianney de Jong; Carin G. Faber; Berry H. P. Kremer; H. Jurgen Schelhaas; Pieter A. van Doorn; Jan J. G. M. Verschuuren; Richard P. M. Bruyn; Jan B. M. Kuks; Wim Robberecht; John H. J. Wokke; Leonard H. van den Berg
Arch Neurol 2009; 66: 509-514.
[Abstract]
[Full text]
[PDF]
- Correspondence
Tissue Plasminogen Activator Does Not Benefit Most Eligible Patients With Stroke
- Maarten G. Lansberg; Neil E. Schwartz
Arch Neurol 2009; 66: 540-a-541-a.
[Extract]
[Full text]
[PDF]
- Correspondence
Tissue Plasminogen Activator Does Not Benefit Most Eligible Patients With Stroke—Reply
- Bryan A. Liang; Robert Lew; Justin A. Zivin
Arch Neurol 2009; 66: 541.
[Extract]
[Full text]
[PDF]
- Clinical Trials
Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
- Parkinson Study Group CALM Cohort Investigators
Arch Neurol 2009.32.
[Abstract]
[Full text]
[]
- Corrections
Omission of Participating Site Investigators/Coordinators in: Randomized Controlled Trial of Ethyl-Eicosapentaenoic Acid in Huntington Disease: The TREND-HD Study
-
Arch Neurol 2009; 66: 305.
[Full text]
[PDF]
|
|
